Alex James Lystrup, PHARMD | |
465 Memorial Dr, Pocatello, ID 83201-4008 | |
(208) 234-4700 | |
Not Available |
Full Name | Alex James Lystrup |
---|---|
Gender | Male |
Speciality | Pharmacist - Pharmacotherapy |
Location | 465 Memorial Dr, Pocatello, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124670831 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835P1200X | Pharmacist - Pharmacotherapy | P8065 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alex James Lystrup, PHARMD 465 Memorial Dr, Pocatello, ID 83201-4008 Ph: () - | Alex James Lystrup, PHARMD 465 Memorial Dr, Pocatello, ID 83201-4008 Ph: (208) 234-4700 |
News Archive
Exelixis, Inc. announced today that it has entered into two new collaboration agreements with Bristol-Myers Squibb Company. Under the first agreement, Exelixis will grant to Bristol-Myers Squibb an exclusive license to its small-molecule TGR5 agonist program including backups.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced updated long-term data from a Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme, the most common and aggressive form of brain cancer.
The Association for Molecular Pathology, the premier global, non-profit organization serving molecular diagnostic professionals, today announced a new report that addresses the challenges in defining the clinical utility of molecular diagnostics for inherited diseases and cancer.
The debate over what to do about Medicare payments to doctors continues. Physicans have been lobbying "to repeal the Sustainable Growth Rate formula, which triggers automatic Medicare payment cuts if spending rises above a certain level," CongressDaily reports. Those cuts have been put off for years.
Alzheimer's disease affects millions of people worldwide. As a result of an increase in life expectancy, the number of patients with dementia is expected to increase dramatically. Due to the lack of effective treatments that can slow down or reverse the progression of AD, preventive measures to lower the prevalence rate of AD by means of managing potential or actual risk factors is a reasonable clinical strategy.
› Verified 4 days ago
Dr. Roger Franklin Murphy, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1015 E Young St, Pocatello, ID 83201 Phone: 208-232-0049 Fax: 208-232-3963 | |
Dr. Jordin Millward, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 465 Memorial Dr, Pocatello, ID 83201 Phone: 208-282-3387 | |
Frances Mary Huber, DR Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 333 W Center St, Pocatello, ID 83204 Phone: 208-233-2063 | |
Spencer Adams, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Yellowstone Ave, Pocatello, ID 83201 Phone: 208-239-4033 Fax: 208-239-4027 | |
Dr. Donelle Airmet, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 990 S 8th Ave, Pocatello, ID 83209 Phone: 208-282-3407 | |
Justin Almond, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 305 W Quinn Rd, Pocatello, ID 83201 Phone: 208-238-4049 | |
Mrs. Cristina Maria Da Silva Comparini, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1957 Alvin Ricken Dr, Pocatello, ID 83201 Phone: 208-236-6340 |